Guggenheim Capital’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-100,251
| Closed | -$413K | – | 1801 |
|
|
2024
Q3 | $413K | Buy |
100,251
+10,307
| +11% | +$55.4K | ﹤0.01% | 1481 |
|
|
2024
Q2 | $586K | Buy |
89,944
+12,754
| +17% | +$90.2K | ﹤0.01% | 1356 |
|
|
2024
Q1 | $672K | Sell |
77,190
-163,681
| -68% | -$1.99M | ﹤0.01% | 1349 |
|
|
2023
Q4 | $2.76M | Sell |
240,871
-15,024
| -6% | -$149K | 0.02% | 731 |
|
|
2023
Q3 | $2.46M | Buy |
255,895
+9,065
| +4% | +$88.8K | 0.02% | 740 |
|
|
2023
Q2 | $2.63M | Sell |
246,830
-72,553
| -23% | -$780K | 0.02% | 742 |
|
|
2023
Q1 | $3.36M | Sell |
319,383
-33,056
| -9% | -$370K | 0.03% | 662 |
|
|
2022
Q4 | $4.37M | Sell |
352,439
-14,799
| -4% | -$168K | 0.04% | 572 |
|
|
2022
Q3 | $3.81M | Buy |
367,238
+102,562
| +39% | +$1.16M | 0.03% | 601 |
|
|
2022
Q2 | $3.05M | Buy |
264,676
+166,184
| +169% | +$1.96M | 0.02% | 738 |
|
|
2022
Q1 | $1.24M | Sell |
98,492
-8,242
| -8% | -$94.5K | 0.01% | 1249 |
|
|
2021
Q4 | $1.25M | Buy |
+106,734
| New | +$1.31M | 0.01% | 1273 |
|
|
2018
Q4 | – | Sell |
-217,458
| Closed | -$3.36M | – | 2262 |
|
|
2018
Q3 | $3.36M | Buy |
217,458
+11,920
| +6% | +$188K | 0.02% | 953 |
|
|
2018
Q2 | $3.29M | Sell |
205,538
-20,097
| -9% | -$297K | 0.02% | 955 |
|
|
2018
Q1 | $2.92M | Buy |
225,635
+5,220
| +2% | +$65.1K | 0.01% | 1374 |
|
|
2017
Q4 | $2.77M | Sell |
220,415
-57,011
| -21% | -$745K | 0.01% | 1426 |
|
|
2017
Q3 | $3.66M | Buy |
277,426
+36,664
| +15% | +$505K | 0.01% | 1246 |
|
|
2017
Q2 | $3.81M | Buy |
240,762
+19,110
| +9% | +$278K | 0.01% | 1177 |
|
|
2017
Q1 | $3.17M | Buy |
221,652
+3,755
| +2% | +$51.3K | 0.01% | 1304 |
|
|
2016
Q4 | $2.79M | Sell |
217,897
-29,919
| -12% | -$378K | 0.01% | 1422 |
|
|
2016
Q3 | $3.3M | Sell |
247,816
-22,490
| -8% | -$263K | 0.01% | 1271 |
|
|
2016
Q2 | $2.96M | Sell |
270,306
-29,029
| -10% | -$284K | 0.01% | 1307 |
|
|
2016
Q1 | $2.74M | Sell |
299,335
-142,410
| -32% | -$1.17M | 0.01% | 1355 |
|
|
2015
Q4 | $4.29M | Sell |
441,745
-161,778
| -27% | -$1.56M | 0.01% | 1088 |
|
|
2015
Q3 | $5.27M | Sell |
603,523
-46,391
| -7% | -$433K | 0.02% | 1006 |
|
|
2015
Q2 | $6.56M | Buy |
649,914
+165,862
| +34% | +$1.93M | 0.02% | 1031 |
|
|
2015
Q1 | $6.49M | Buy |
484,052
+83,717
| +21% | +$1.1M | 0.02% | 1043 |
|
|
2014
Q4 | $5.14M | Buy |
400,335
+33,512
| +9% | +$384K | 0.01% | 1109 |
|
|
2014
Q3 | $3.98M | Buy |
366,823
+45,934
| +14% | +$526K | 0.01% | 1334 |
|
|
2014
Q2 | $4.12M | Sell |
320,889
-79,740
| -20% | -$867K | 0.01% | 1305 |
|
|
2014
Q1 | $4.13M | Buy |
400,629
+45,179
| +13% | +$508K | 0.01% | 1233 |
|
|
2013
Q4 | $3.46M | Sell |
355,450
-22,911
| -6% | -$206K | 0.01% | 1311 |
|
|
2013
Q3 | $3.75M | Sell |
378,361
-119,710
| -24% | -$1.17M | 0.01% | 1246 |
|
|
2013
Q2 | $4.15M | Buy |
+498,071
| New | +$6.04M | 0.02% | 1144 |
|
Other funds holding IRWD
SCM
AC
B
KCM
Guggenheim Capital's IRWD Position: Q4 2024 in Review
Guggenheim Capital sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2024, closing a stake of 100,251 shares — an estimated $413K sold.
Guggenheim Capital first reported a position in IRWD in Q2 2013 and held it in 34 quarters. The position peaked at $6.56M in Q2 2015. 223 funds tracked by Wall St. Rank hold IRWD as of Q4 2024.
- Guggenheim Capital reported no remaining Ironwood Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
- Guggenheim Capital sold 100,251 Ironwood Pharmaceuticals shares in Q4 2024, an estimated $413K.
- Guggenheim Capital first reported a position in Ironwood Pharmaceuticals in Q2 2013 and held it in 34 quarters.
- Guggenheim Capital's Ironwood Pharmaceuticals position peaked at $6.56M in Q2 2015.
- 223 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2024.
Based on Guggenheim Capital's 13F filing for Q4 2024, filed 13 Feb 2025.